Related Experiment Video
Updated: Aug 9, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Mediator is a transducer of Wnt/beta-catenin signaling
Seokjoong Kim1, Xuan Xu, Andreas Hecht
1Department of Molecular Medicine and the Institute of Biotechnology, University of Texas Health Science Center, San Antonio, Texas 78245-3207, USA.
Abstract:
Signal transduction within the canonical Wnt/beta-catenin pathway drives development and carcinogenesis through programmed or unprogrammed changes in gene transcription. Although the upstream events linked to signal-induced activation of beta-catenin in the cytoplasm have been deciphered in considerable detail, much less is known regarding the mechanism by which beta-catenin stimulates target gene transcription in the nucleus. Here, we show that beta-catenin physically and functionally targets the MED12 subunit in Mediator to activate transcription. The beta-catenin transactivation domain bound directly to isolated MED12 and intact Mediator both in vitro and in vivo, and Mediator was recruited to Wnt-responsive genes in a beta-catenin-dependent manner. Disruption of the beta-catenin/MED12 interaction through dominant-negative interference- or RNA interference-mediated MED12 suppression inhibited beta-catenin transactivation in response to Wnt signaling. This study thus identifies the MED12 interface within Mediator as a new component and a potential therapeutic target in the Wnt/beta-catenin pathway.
Insights
Beta-catenin (a key protein in cell development and cancer) directly interacts with MED12, a component of the Mediator complex. This interaction is crucial for activating gene transcription in the Wnt/beta-catenin pathway.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The canonical Wnt/beta-catenin pathway regulates gene transcription crucial for development and cancer.
- While upstream signaling is understood, nuclear mechanisms of beta-catenin-mediated transcription remain unclear.
Purpose of the Study:
- To elucidate the nuclear mechanism of beta-catenin in target gene transcription.
- To identify novel protein interactions of beta-catenin in the nucleus.
Main Methods:
- In vitro and in vivo binding assays to test beta-catenin and MED12 interaction.
- Recruitment assays to monitor Mediator complex binding to Wnt-responsive genes.
- Dominant-negative interference and RNA interference to disrupt the beta-catenin/MED12 interaction.
Main Results:
- Beta-catenin directly binds to the MED12 subunit of the Mediator complex.
- Mediator complex is recruited to Wnt-responsive genes in a beta-catenin-dependent manner.
- Disruption of the beta-catenin/MED12 interaction inhibits Wnt-induced gene transcription.
Conclusions:
- Identifies MED12 as a key nuclear interaction partner for beta-catenin.
- Establishes the beta-catenin/MED12 interface as a critical component of the Wnt/beta-catenin pathway.
- Suggests the MED12 interface as a potential therapeutic target for Wnt pathway-driven diseases.
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
TGF - β Signaling Pathway
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin homology) domains...
